Hepatitis B and C are chronic viral infections that silently damage the liver for years or decades, ultimately causing cirrhosis, liver failure, and liver cancer in a significant proportion of untreated patients. Approximately 1.2 million Americans have chronic hepatitis B and 2.4 million have chronic hepatitis C — and the majority are undiagnosed. Medical clinics play a critical role in identifying these infections through routine testing so that effective treatment can be offered before liver damage becomes irreversible. This guide explains hepatitis B and C testing and its clinical importance.
Hepatitis B Testing
Hepatitis B testing involves a panel of surface antigens and antibodies: HBsAg (hepatitis B surface antigen — positive in active infection), anti-HBs (antibody to surface antigen — positive after vaccination or resolved infection), anti-HBc (core antibody — marker of past exposure), and when indicated, HBV DNA (viral load — confirming active replication). The CDC now recommends one-time universal hepatitis B screening for all adults regardless of risk factors.
Hepatitis C Testing
Hepatitis C testing uses a two-step approach: initial antibody test (HCV Ab) detecting prior exposure, followed by HCV RNA (viral load) testing to confirm active infection when the antibody test is positive. The USPSTF recommends one-time hepatitis C screening for all adults ages 18–79. People born between 1945 and 1965 (Baby Boomers) have the highest prevalence and particularly benefit from screening.
Why Testing Matters Now More Than Ever
Hepatitis C is now curable with 8–12 week courses of direct-acting antiviral medications achieving >95% cure rates with minimal side effects — a medical breakthrough that transforms the significance of testing. Identifying and treating hepatitis C prevents cirrhosis, liver cancer, and liver failure. The only barrier to cure is the test not being done.
Conclusion
Hepatitis B and C testing should be a standard part of every adult’s healthcare — not a test reserved for “high-risk” individuals. Ask your clinic about your hepatitis B and C testing status at your next visit. A positive result is no longer a sentence — it is the beginning of treatment that protects your liver for life.
FAQs – Hepatitis Testing
Q1. Can I have hepatitis C without knowing?
A: Yes. Hepatitis C typically produces no symptoms for decades while silently damaging the liver. Most people with chronic hepatitis C are unaware of their infection until detected through screening or until symptoms of advanced liver disease develop.
Q2. Is there a vaccine for hepatitis C?
A: No vaccine exists for hepatitis C. Prevention relies on avoiding exposure (not sharing needles, safe tattooing and piercing practices, safe sex). An effective vaccine for hepatitis B has been available since the 1980s and is recommended for all infants and unvaccinated adults.
Q3. What if I test positive for hepatitis C?
A: A positive antibody test requires confirmatory HCV RNA testing. If active infection is confirmed, referral to a hepatologist or gastroenterologist initiates the treatment evaluation. Modern direct-acting antiviral regimens cure hepatitis C in >95% of patients within 8–12 weeks.
Q4. Does a positive hepatitis C antibody mean I currently have hepatitis C?
A: Not necessarily. About 25% of people who contract hepatitis C spontaneously clear the infection without treatment. They test antibody-positive (evidence of past exposure) but HCV RNA-negative (no active infection). HCV RNA testing distinguishes past from current infection.
Q5. Can hepatitis B be cured?
A: Chronic hepatitis B cannot currently be cured — antiviral medications suppress viral replication and prevent progression but do not eliminate the virus. Functional cure (loss of HBsAg) occurs in a minority of patients on treatment. Research into hepatitis B cure strategies is advancing.
